National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 73665 [2024-20500]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 176 / Wednesday, September 11, 2024 / Notices
• Deep experience in the
complexities of data sharing across
institutions and the technical aspects of
linking data.
• Access to and adherence to
protections for restricted datasets.
Carole Johnson,
Administrator.
[FR Doc. 2024–20570 Filed 9–10–24; 8:45 am]
BILLING CODE 4165–15–P
Contact Person: Sushmita Purkayastha,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Extramural Program,
Arthritis and Musculoskeletal and Skin
Diseases, 6701 Democracy Boulevard, Room
814, Bethesda, MD 20817, 301–201–7600,
sushmita.purkayastha@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: September 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–20500 Filed 9–10–24; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group: Arthritis and Musculoskeletal
and Skin Diseases Special Grants Study
Section.
Date: October 17–18, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Scientific Review
Officer; Scientific Review Branch, Extramural
Program, Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Boulevard,
Room 820, Bethesda, MD 30892, 301–827–
7835, yasuko.furumoto@nih.gov.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group: Arthritis and Musculoskeletal
and Skin Diseases Clinical Trials Study
Section.
Date: October 24–25, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
VerDate Sep<11>2014
17:42 Sep 10, 2024
Jkt 262001
National Institutes of Health
National Eye Institute; Notice of
Partially Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Eye
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who would like to attend
the meeting in person as an observer
must email the contact person below 5
days in advance of the meeting with
their affiliation if applicable.
Those who need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the Contact Person listed
below in advance of the meeting. The
open session will be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov/watch=55153).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: October 11, 2024.
Open: 8:30 a.m. to 2:30 p.m.
Agenda: Presentation of the NEI Director’s
report, discussion of NEI programs, and
concept clearances.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
73665
Place: National Eye Institute, 1st Floor,
Room A/B/C 6700B, Rockledge Drive,
Bethesda, MD 20892 (In Person).
Closed: 2:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Eye Institute, 1st Floor,
Room A/B/C, 6700B Rockledge Drive,
Bethesda, MD 20892 (In Person).
Contact Person: Kathleen C. Anderson,
Ph.D., Director, 6700B Rockledge Drive,
Room 3440, Bethesda, MD 20892, (301) 827–
4320, kanders1@nei.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. In the
interest of security, NIH has procedures at
https://www.nih.gov/about-nih/visitorinformation/campus-access-security for
entrance into on-campus and off-campus
facilities. All visitor vehicles, including
taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus.
Visitors attending a meeting on campus or at
an off-campus federal facility will be asked
to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nei.nih.gov/about/advisory-committees/
national-advisory-eye-council-naec, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: September 5, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–20433 Filed 9–10–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
E:\FR\FM\11SEN1.SGM
11SEN1
]]>Agencies
[Federal Register Volume 89, Number 176 (Wednesday, September 11, 2024)]
[Notices]
[Page 73665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20500]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group: Arthritis and Musculoskeletal and
Skin Diseases Special Grants Study Section.
Date: October 17-18, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yasuko Furumoto, Ph.D., Scientific Review
Officer, Scientific Review Officer; Scientific Review Branch,
Extramural Program, Arthritis and Musculoskeletal and Skin Diseases,
6701 Democracy Boulevard, Room 820, Bethesda, MD 30892, 301-827-
7835, [email protected].
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group: Arthritis and Musculoskeletal and
Skin Diseases Clinical Trials Study Section.
Date: October 24-25, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sushmita Purkayastha, Ph.D., Scientific Review
Officer, Scientific Review Branch, Extramural Program, Arthritis and
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Room
814, Bethesda, MD 20817, 301-201-7600, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: September 5, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-20500 Filed 9-10-24; 8:45 am]
BILLING CODE 4140-01-P
